Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.47 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.41 |
| ▸ | PRKDC | P78527 | 12/20 | 0.39 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.39 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.38 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.33 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.33 |
| ▸ | PLA2G2A | P14555 | 2/20 | 0.32 |
| ▸ | PLA2G4A | P47712 | 2/20 | 0.32 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26323872 | 0.87 | ALOX5 (0.42) | ALOX5GGPS1PRKDCPTGES2PRMT5 | |
| SCHEMBL179182 | 0.83 | ALOX5 (0.37) | ALOX5GGPS1PRKDCPRMT5WDR77 | |
| SCHEMBL22292711 | 0.82 | ALOX5 (0.42) | ALOX5GGPS1PRKDCPTGES2PRMT5 | |
| SCHEMBL25100455 | 0.82 | ALOX5 (0.40) | ALOX5GGPS1PRKDCPTGES2PRMT5 | |
| SCHEMBL22622635 | 0.82 | ALOX5 (0.41) | ALOX5GGPS1PRKDCPTGES2PRMT5 | |
| SCHEMBL12996518 | 0.82 | ALOX5 (0.65) | ALOX5GGPS1PRKDCPTGES2PRMT5 | |
| SCHEMBL12698455 | 0.82 | ALOX5 (0.42) | ALOX5GGPS1PRKDCPRMT5WDR77 | |
| SCHEMBL20143225 | 0.82 | ALOX5 (0.41) | ALOX5GGPS1PRKDCPTGES2PRMT5 | |
| SCHEMBL18177218 | 0.82 | ALOX5 (0.37) | ALOX5GGPS1PRKDCPRMT5WDR77 | |
| SCHEMBL13050915 | 0.81 | ALOX5 (0.44) | ALOX5GGPS1PRKDCPTGES2PRMT5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7846560-B2 | Material for organic electroluminescence device and electroluminescence device employing the same | IDEMITSU KOSAN CO., LTD. (JP) | 2010-12-07 | — | — | US | disclosed |
| US-20100084971-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2010-04-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100084971-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME | L1CAM, EPCAM, EML4 | ALOX5 3800/4885GGPS1 2457/4885PRKDC 2210/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.